Sorrento Therapeutics (SRNE) Stock Price, News & Analysis
Company Description
Sorrento Therapeutics (OTC Link: SRNE) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.9M.
SRNE has declined 73.3% over the past year. Shares last traded at $0.0004.
For FY2022, Sorrento Therapeutics reported revenue of $62.8M with net income of -$572.8M and diluted earnings per share of -$1.37. The company operates at a net profit margin of -911.6%.
This page collects what Stock Titan holds for SRNE, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Sorrento Therapeutics (SRNE) stock last closed at $0.0004. Over the past 12 months, the stock has lost 73.3%. At a market capitalization of $1.9M, SRNE is classified as a micro-cap stock with approximately 551.3M shares outstanding.
Latest News
Sorrento Therapeutics has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include dividends, acquisition, fda approval. View all SRNE news →
SEC Filings
Financial Highlights
Sorrento Therapeutics generated $62.8M in revenue in FY2022, operating income reached -$504.3M (-802.5% operating margin), and net income was -$572.8M, reflecting a -911.6% net profit margin. Diluted earnings per share stood at -$1.37. The company generated -$293.9M in operating cash flow. With a current ratio of 0.29, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Sorrento Therapeutics (SRNE) currently stands at 3.5 million shares, up 0.2% from the previous reporting period, representing 0.6% of the float. This relatively low short interest suggests limited bearish sentiment. The 7.0 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Sorrento Therapeutics (SRNE) currently stands at 7.0 days, down 28.1% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 70.6% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 27.2 days.
SRNE Company Profile & Sector Positioning
Sorrento Therapeutics (SRNE) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing SRNE often look at related companies in the same sector, including Aim Immunotech (AIMI), Enzolytics (ENZC), Neon Bloom (NBCO), GREY MATTERS HEALTH INC, (AGNPF), and Axim Biotechnologies Inc (AXIM). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SRNE's relative position within its industry.